Navigation Links
RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
Date:2/8/2013

r 1000 male to 2.8 per 1000 female children, averaged at 3.2 per 1000 children, which is expected to increase due to reduction of premature death.

In the clinical study investigators employ a variety of methods to assess efficacy: K-ABC: Kaufman Assessment Battery for Children, Gross Motor Function Measure, (GMFM), box and block test, Modified Asworth Scale, MAS, finger tapping test, Brain SPECT and MRI.

Dr. JC Ra, president of RNL BIO Stem Cell Technology Institute, said, "It is our mission to find cures for incurable diseases, such as the terrible pediatric curse of cerebral palsy, through autologous stem cell technology." 

About RNL BIO

RNL BIO is a premier biotechnology company focused on the research and development of adult derived stem cell technologies. RNL has completed one phase I trial for spinal cord injury and one Phase II clinical trial for Osteoarthritis and is near to the completion of Buerger's Disease trial. RNL has been a supporter of UN Global Compact's free program to work with children who suffer from cerebral palsy, as major sponsor of the Bethesda Life Foundation. RNL is a publicly traded company on the Korean Stock Exchange (Code 003190) and is expanding its operations throughout the world.


'/>"/>
SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
2. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
3. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
6. Lotus Pharmaceutical Company Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) with the U.S. Food & Drug Administration (FDA)
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... HILL, N.C. , Dec. 19, 2014 /PRNewswire/ ... innovative consumer research and marketing communication tools are ... and globally competitive – consequently consumers, desires, preferences, ... In this environment, market research groups across all ... and marketing communication tools. However, the adoption of ...
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
(Date:12/19/2014)... Calif. , Dec. 18, 2014  Sage ... new generation of equipment for the testing of ... release of the new Luminary™ Profiler, the industry,s ... light-based measurement in a cost-effective, portable unit. ... the specific needs of the cannabis industry, the ...
Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
... announced today that TRAKnet Practice Management Software 2.0 is ... EHR on October 28th, 2010 by the Certification ... accordance with the applicable Eligible Provider certification criteria adopted ... 2011/2012 criteria support the Stage 1 meaningful use measures ...
... MedSolutions ( www.medsolutions.com ), a leading provider of medical ... Institute and the Office of Continuing Education at Tufts ... webinar designed to assist primary care physicians and pediatricians ... "Doing the Right Thing: Diagnostic Radiology, Radiation Risk, and ...
Cached Medicine Technology:BioMedix's TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification 2BioMedix's TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification 3BioMedix's TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification 4MedSolutions Offers Free CME Credit Imaging Safety Webinar for Physicians 2MedSolutions Offers Free CME Credit Imaging Safety Webinar for Physicians 3
(Date:12/22/2014)... (PRWEB) December 22, 2014 Give a ... season, the gift of health and vitality. , For ... its three top-selling anti-aging formulas in special Holiday Wellness ... rush delivery. , Each bottle contains cutting-edge, proven ... that don't work as well as we age. ...
(Date:12/22/2014)... York NY (PRWEB) December 22, 2014 ... that a federal panel of judges has granted a ... in the U.S. District Court, Eastern District of ... issued an order on December 12 to transfer over ... in 22 districts to the Louisiana court for consolidation ...
(Date:12/22/2014)... Petersburg, FL (PRWEB) December 22, 2014 Christmas ... Sublime Beauty® has a fast and easy solution that will ... gift cards can be purchased from from $25 up to ... "We offer 100% customer satisfaction and a wide array of ... have no fees and no expiration dates. , Gift ...
(Date:12/22/2014)... Washington, DC (PRWEB) December 22, 2014 ... begins its year-long, professional development programs this month. ... LEAD, which focuses on nurse educators fast-tracked for ... for the Leadership Development Program for Simulation Educators, ... that specialized area of nursing education. , ...
(Date:12/21/2014)... December 22, 2014 Recently, BambooFlooringChina.com, a ... strand woven bamboo flooring collection , and launched a ... The promotion is valid until Jan. 30, 2015. , ... bamboo is the hardest bamboo flooring available today; it ... that of traditional teak hardwoods. Strand woven bamboo is ...
Breaking Medicine News(10 mins):Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2
... The U.S. Preventive Services Task Force (USPSTF), updating its ... for men over the age of 75. More evidence ... benefit from screening. , Previously, the Task Force ... screening for all men, and found inconclusive evidence that ...
... Thessaloniki, Greece - August 4, 2008 - A recent ... demonstrated that Erythropoiesis-stimulating agents (ESAs), a widely used drug ... the survival of myeloma patients. In the study, 323 ... period in Greece from 1988 to 2007. The investigators ...
... hazards outweigh benefits, government task force reports , , MONDAY, ... a dim view of prostate cancer screenings at any ... over 75. , The over-75 rule "is much more ... using the prostate-screening antigen (PSA) test, said Dr. Michael ...
... Increases 36% to $16.9 Million ... Record ... 4 ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... the,second quarter ended June 28, 2008. Revenue for the quarter was ...
... LOS ALTOS, Calif., Aug. 4 InteKrin Therapeutics, ... development of,products for diabetes, metabolism and obesity today ... Series C venture financing for $18.25,million. The financing ... CA and,Managing Director David Lowe Ph.D. of Skyline ...
... Aug. 4 Susan Reichle, the U.S.,Agency for ... the mission director. The promotion took place this ... of office during a,brief ceremony., "Susan,s appreciation ... and the agency well in her new position," ...
Cached Medicine News:Health News:Treatment with anti-anemia drugs may not be safe for multiple myeloma patients 2Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 2Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 3Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 4Health News:ATS Medical Announces Second Quarter Results 2Health News:ATS Medical Announces Second Quarter Results 3Health News:ATS Medical Announces Second Quarter Results 4Health News:ATS Medical Announces Second Quarter Results 5Health News:ATS Medical Announces Second Quarter Results 6Health News:ATS Medical Announces Second Quarter Results 7Health News:ATS Medical Announces Second Quarter Results 8Health News:ATS Medical Announces Second Quarter Results 9Health News:ATS Medical Announces Second Quarter Results 10Health News:InteKrin Therapeutics Announces $20 Million Series C Financing 2
Fulgurating Electrode, 3 F...
ACMI S-Series Cystourethroscope Systems: Precision instruments designed for superior optical recognition, accurate control, and exceptional durability during steam autoclave sterilization....
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use....
Inquire...
Medicine Products: